Educational model only. This site shows simplified half-life, accumulation, washout, supply, and device-arithmetic estimates from user-entered assumptions. Reported, research, trial-style, community, or placeholder examples are not recommendations. It is not medical advice, dosing advice, prescribing guidance, compounding guidance, reconstitution guidance, pharmacy guidance, or injection instruction. Real medication or peptide decisions must be made only with a licensed clinician or pharmacist and the official materials for the exact product.

Live model

Current model summary

Total mg used
Avg per week
Modeled events
Max peak
Min model level
Final level
Supply needed

Exposure curve

Accumulation and washout

Combined Components Events
Custom model events (first 20)
Event #WhenInput mgPen-click arithmeticModel dayPre mgPost mg
Exposure and washout math
// Each modeled event contributes independently:
contributionᵢ(t) = Dᵢ · (½)^((t − tᵢ)/t½)

// The charted total is the sum of all active contributions:
total(t) = Σᵢ contributionᵢ(t)

// After the last modeled event:
total(t) continues decaying by the selected half-life until the residual level stops materially changing the chart
What this model does: let you enter hypothetical phase inputs, then plot dose-equivalent model levels over time. It shows simplified accumulation while modeled events continue and washout as the selected half-life reduces the model level. The results are dose-equivalent model levels, not measured blood concentrations, personalized pharmacokinetics, or treatment instructions.

Supply estimate: total milligrams are summed from the displayed simulation window using the selected device type. When pen or vial capacities are configured, supply planning compares all-smallest, mixed, and all-largest capacity options. Retatrutide vial entries are generic capacity estimates only because Retatrutide has no approved commercial retail product data.

Event table: choose a first modeled event date/time and pen/click arithmetic basis above. The table shows each modeled event number, calendar date, weekday/time, input amount, and click arithmetic when a click basis is available. These are model outputs only, not instructions for use.

Reading the chart: the bold teal curve is the cumulative model level (superposition of every active modeled event). The x-axis uses calendar dates plus model day, and the view continues after the final event only while the washout tail still materially affects the model. The faint violet dashed curves are each individual event contribution waning over its own half-life. Hover anywhere to snap to a calendar day and see meaningful prior-event washout contributions.

Custom inputs: define amount / interval / repeat-count phases and watch how the cumulative model level ramps, re-equilibrates, and washes out as it crosses phase boundaries. Presets are examples only and change with the selected entry.

Stacks: combinations such as BPC-157 + TB-500 or CJC-1295 + Ipamorelin contain compounds with different half-lives. Stack selections model each component separately, then chart a normalized combined exposure index so unlike milligram amounts are not treated as the same concentration.

Caveats: this is a simple immediate-input, first-order decay model. Real absorption, metabolism, product quality, formulation, route, interactions, and individual response can differ materially. Any real-world medication, peptide, vial, device, route, concentration, amount, or timing decision must be handled by a licensed clinician or pharmacist using the official materials for the exact product.

Peptide Half-Life and Educational Exposure Model

This educational peptide half-life calculator models hypothetical microdosing and micro-dosing exposure inputs for GLP-1 and related medications. It can show simplified modeled accumulation, steady exposure, and washout for semaglutide, tirzepatide, retatrutide, dulaglutide, and liraglutide products such as Ozempic, Wegovy, Zepbound, Mounjaro, Trulicity, Saxenda, and Victoza. It also includes research-only and peptide-adjacent entries such as BPC-157, TB-500, thymosin alpha-1, GHK-Cu, AOD-9604, CJC-1295, Ipamorelin, GHRP-2, GHRP-6, MOTS-c, Epitalon, Selank, Semax, DSIP, Kisspeptin-10, Melanotan II, Bremelanotide, and Orforglipron.

Half-life and washout

A medication half-life is the time it takes for the modeled amount in the system to fall by half. The chart extends beyond the last modeled event to show the washout tail in this simplified first-order decay model.

Hypothetical exposure inputs

Build an educational scenario by entering an amount in milligrams, a model interval in days, and a repeat count. The calculator totals each modeled event and overlays the combined exposure line with optional individual event curves.

Pens, vials, and clicks

For supported devices, the supply estimate compares pen or vial capacities and shows click-count arithmetic when a real click basis is available, including KwikPen arithmetic for compatible tirzepatide devices. This is not device instruction.

Common searches this calculator helps with